Aprimavera chegou, antecipando um provavel verao profissional, ao menos no Rio deJaneiro, onde estou. Desde a ultima estacao estou devendo movimento nesteblog. Decidi compartilhar o motivo deste silencio com voces.Entao, vamos la. A Quimica Medicinal tem amplocarater interdisciplinar, onde dentre as disciplinas relevantes, a Farmacologiae a Quimica Medicinal propriamente dita, sao as centrais, imprescindiveis aodesenho e planejamento racional de novas moleculas capazes de representaremautenticos candidatos a novos farmacos. Dentre as fontes bibliograficas que nospermitem atualizacao cientifica continua, alem dos periodicos indexados e livros,considero que a participacao em congressos cientificos e uma das maisrelevantes. Se de um lado, podemos submeter os resultados de nossos projetos depesquisa, nao confidenciais, ao crivo de nossos pares, inclusive de outras pracas,por outro, podemos confronta-los com aqueles apresentados por especialistasatraves de suas palestras ou conferencias que, tematicas ou nao, nos esclarecemsobre o que esta sendo realizado pelos Colegas especialistas de uma determinadaarea de interesse, num autentico up-to-date!Pois exatamente por estar envolvido na organizacao do 8th Brazilian Symposiumon Medicinal Chemistry, mais conhecido como BrazMedChem2016, fiquei com menos tempo, imobilizando este blog,temporariamente. Nesta resenha ou post, decidi que seria interessante registrara proximidade do BrazMedChem 2016, que se inicia ao final do mes de 26 a 30 de novembro, nas dependencias do Hotel Atlantico de Buzios, RJ. A seguir, coloco a lista dos conferencistas participantese os respectivos titulos de suas apresentacoes:1. Simon Campbell, Independent Advisor,Poole, United Kingdom.OpeningConference: Science, art, and drug discovery: a personal perspective.2. Alan P. Kozikowski, University ofIllinois at Chicago, USA. Title:Designing histone deacetylase (HDAC) inhibitors for use as CNS and cancertherapeutics Whats easy and whats not...3. Ana Martinez Gil, Biological ResearchCenter, Spanish Council for Research, Spain.Title:Discovering new drugs for Parkinson s disease: from the lab to the clinicaltrials.4. Carlos Alberto Manssour Fraga, FederalUniversity of Rio de Janeiro, Brazil.Title:Discovery of multitarget prototypes for treatment of multifactorial diseases: N-acylhydrazone framework as privilegedstructure.5. Flavio da Silva Emery, University of SaoPaulo at Ribeirao Preto, Brazil.Title:Exploring opportunities in the chemical space to develop a library ofheterocycles.6. Gyorgy Miklos Keseru, Hungarian Academyof Sciences, Hungary.Title:Exploiting secondary binding pockets in aminergic GPCRs.7. Helmut Buschmann, Research, Development& Consulting GmbH (RD&C), Austria.Title:Medicinal Chemistry, quo vadis? A personal view backwards on successful drugdiscoveries within the changing climate of pharmaceutical R&D.8. Holger Stark, Heinrich-Heine University ofDusseldorf, Germany.Title:Histamine H3 Receptor Antagonist From bench to bedside and back to bench.9. Hugo Cerecetto, University of theRepublic, Uruguay.Title:Looking for hybrid agents with potential use in BNCT of glioblastomamultiforme: Tyrosine kinase inhibitors hybridized with boron clusters.10. Jose Duca, Novartis Institutes forBioMedical Research, USA.Title:Impacting drug discovery with computational chemistry: next generation methodsand ideas.11. Koen Augustyns, University of Antwerp. Belgium.Title:Activity-based probes: Novel tools for chemical biology and drug discovery.12. Madalena M. M. Pinto, University of Porto/ CIIMAR, Portugal.Title:Nature-mimetic small molecules: From the land, from the sea, from the lab andthrough the looking-glass...13. Maria Laura Bolognesi, University ofBologna, Italy.Title:Navigating the chemical Space of multitarget-directed ligands: From hybrids tofragments in alzheimers disease.14. Patrick M. Woster, Medical University ofSouth Carolina, USA.Title:Small molecule epigenetic modulators of gene expression for use in non-cancerdiseases.15. Rob Leurs, Vrije University, Netherlands.Title:Phosphodieasterase Inhibitors as a Potential Treatment for Neglected ParasiticDiseases.16. Valeria de Oliveira, Federal University ofGoias,